These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37734653)

  • 1. A roadmap to strengthen standardisation efforts in risk governance of nanotechnology.
    Rasmussen K; Bleeker EAJ; Baker J; Bouillard J; Fransman W; Kuhlbusch TAJ; Resch S; Sergent JA; Soeteman-Hernandez LG; Suarez-Merino B; Porcari A
    NanoImpact; 2023 Oct; 32():100483. PubMed ID: 37734653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation.
    Halamoda-Kenzaoui B; Vandebriel RJ; Howarth A; Siccardi M; David CAW; Liptrott NJ; Santin M; Borgos SE; Bremer-Hoffmann S; Caputo F
    J Control Release; 2021 Aug; 336():192-206. PubMed ID: 34126169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanofiltration and nanostructured membranes--should they be considered nanotechnology or not?
    Mueller NC; van der Bruggen B; Keuter V; Luis P; Melin T; Pronk W; Reisewitz R; Rickerby D; Rios GM; Wennekes W; Nowack B
    J Hazard Mater; 2012 Apr; 211-212():275-80. PubMed ID: 22154870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European and international standardisation progress in the field of engineered nanoparticles.
    Rivière G
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():2-7. PubMed ID: 19558227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory landscape of nanotechnology and nanoplastics from a global perspective.
    Allan J; Belz S; Hoeveler A; Hugas M; Okuda H; Patri A; Rauscher H; Silva P; Slikker W; Sokull-Kluettgen B; Tong W; Anklam E
    Regul Toxicol Pharmacol; 2021 Jun; 122():104885. PubMed ID: 33617940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blueprint for a self-sustained European Centre for service provision in safe and sustainable innovation for nanotechnology.
    Marcoulaki E; López de Ipiña JM; Vercauteren S; Bouillard J; Himly M; Lynch I; Witters H; Shandilya N; van Duuren-Stuurman B; Kunz V; Unger WES; Hodoroaba VD; Bard D; Evans G; Jensen KA; Pilou M; Viitanen AK; Bochon A; Duschl A; Geppert M; Persson K; Cotgreave I; Niga P; Gini M; Eleftheriadis K; Scalbi S; Caillard B; Arevalillo A; Frejafon E; Aguerre-Chariol O; Dulio V
    NanoImpact; 2021 Jul; 23():100337. PubMed ID: 35559838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Governance of Emerging Technologies Demonstrated in Terms of its Applicability to Nanomaterials.
    Isigonis P; Afantitis A; Antunes D; Bartonova A; Beitollahi A; Bohmer N; Bouman E; Chaudhry Q; Cimpan MR; Cimpan E; Doak S; Dupin D; Fedrigo D; Fessard V; Gromelski M; Gutleb AC; Halappanavar S; Hoet P; Jeliazkova N; Jomini S; Lindner S; Linkov I; Longhin EM; Lynch I; Malsch I; Marcomini A; Mariussen E; de la Fuente JM; Melagraki G; Murphy F; Neaves M; Packroff R; Pfuhler S; Puzyn T; Rahman Q; Pran ER; Semenzin E; Serchi T; Steinbach C; Trump B; Vrček IV; Warheit D; Wiesner MR; Willighagen E; Dusinska M
    Small; 2020 Sep; 16(36):e2003303. PubMed ID: 32700469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future perspectives for advancing regulatory science of nanotechnology-enabled health products.
    Halamoda-Kenzaoui B; Geertsma R; Pouw J; Prina-Mello A; Carrer M; Roesslein M; Sips A; Weltring KM; Spring K; Bremer-Hoffmann S
    Drug Deliv Transl Res; 2022 Sep; 12(9):2145-2156. PubMed ID: 35691982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment principle for engineered nanotechnology in food and drug.
    Hwang M; Lee EJ; Kweon SY; Park MS; Jeong JY; Um JH; Kim SA; Han BS; Lee KH; Yoon HJ
    Toxicol Res; 2012 Jun; 28(2):73-9. PubMed ID: 24278592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomaterials, a New Challenge in the Workplace.
    Alberto AR; Matos C; Carmona-Aparicio G; Iten M
    Adv Exp Med Biol; 2022; 1357():379-402. PubMed ID: 35583652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardisation in the field of nanotechnology: some issues of legitimacy.
    Forsberg EM
    Sci Eng Ethics; 2012 Dec; 18(4):719-39. PubMed ID: 21424592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoscale reference materials for environmental, health and safety measurements: needs, gaps and opportunities.
    Stefaniak AB; Hackley VA; Roebben G; Ehara K; Hankin S; Postek MT; Lynch I; Fu WE; Linsinger TP; Thünemann AF
    Nanotoxicology; 2013 Dec; 7(8):1325-37. PubMed ID: 23061887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardising Responsibility? The Significance of Interstitial Spaces.
    Wickson F; Forsberg EM
    Sci Eng Ethics; 2015 Oct; 21(5):1159-80. PubMed ID: 25344842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Governance of nanotechnology and nanomaterials: principles, regulation, and renegotiating the social contract.
    Kimbrell GA
    J Law Med Ethics; 2009; 37(4):706-23. PubMed ID: 20122111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards harmonisation of testing of nanomaterials for EU regulatory requirements on chemical safety - A proposal for further actions.
    Bleeker EAJ; Swart E; Braakhuis H; Fernández Cruz ML; Friedrichs S; Gosens I; Herzberg F; Jensen KA; von der Kammer F; Kettelarij JAB; Navas JM; Rasmussen K; Schwirn K; Visser M
    Regul Toxicol Pharmacol; 2023 Mar; 139():105360. PubMed ID: 36804527
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.